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Background: Smoking cessation is a persistent leading public health challenge. Mobile health (mHealth) solutions are emerging
to improve smoking cessation treatments. Previous approaches have proposed supporting cessation with tailored motivational
messages. Some managed to provide short-term improvements in smoking cessation. Yet, these approaches were either static in
terms of personalization or human-based nonscalable solutions. Additionally, long-term effects were neither presented nor assessed
in combination with existing psychopharmacological therapies.
Objective: This study aimed to analyze the long-term efficacy of a mobile app supporting psychopharmacological therapy for
smoking cessation and complementarily assess the involved innovative technology.
Methods: A 12-month, randomized, open-label, parallel-group trial comparing smoking cessation rates was performed at Virgen
del Rocío University Hospital in Seville (Spain). Smokers were randomly allocated to a control group (CG) receiving usual care
(psychopharmacological treatment, n=120) or an intervention group (IG) receiving psychopharmacological treatment and using
a mobile app providing artificial intelligence–generated and tailored smoking cessation support messages (n=120). The secondary
objectives were to analyze health-related quality of life and monitor healthy lifestyle and physical exercise habits. Safety was
assessed according to the presence of adverse events related to the pharmacological therapy. Per-protocol and intention-to-treat
analyses were performed. Incomplete data and multinomial regression analyses were performed to assess the variables influencing
participant cessation probability. The technical solution was assessed according to the precision of the tailored motivational
smoking cessation messages and user engagement. Cessation and no cessation subgroups were compared using t tests. A voluntary
satisfaction questionnaire was administered at the end of the intervention to all participants who completed the trial.
Results: In the IG, abstinence was 2.75 times higher (adjusted OR 3.45, P=.01) in the per-protocol analysis and 2.15 times
higher (adjusted OR 3.13, P=.002) in the intention-to-treat analysis. Lost data analysis and multinomial logistic models showed
different patterns in participants who dropped out. Regarding safety, 14 of 120 (11.7%) IG participants and 13 of 120 (10.8%)
CG participants had 19 and 23 adverse events, respectively (P=.84). None of the clinical secondary objective measures showed
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relevant differences between the groups. The system was able to learn and tailor messages for improved effectiveness in supporting
smoking cessation but was unable to reduce the time between a message being sent and opened. In either case, there was no
relevant difference between the cessation and no cessation subgroups. However, a significant difference was found in system
engagement at 6 months (P=.04) but not in all subsequent months. High system appreciation was reported at the end of the study.
Conclusions: The proposed mHealth solution complementing psychopharmacological therapy showed greater efficacy for
achieving 1-year tobacco abstinence as compared with psychopharmacological therapy alone. It provides a basis for artificial
intelligence–based future approaches.
Trial Registration: ClinicalTrials.gov NCT03553173; https://clinicaltrials.gov/ct2/show/NCT03553173
International Registered Report Identifier (IRRID): RR2-10.2196/12464
(JMIR Mhealth Uhealth 2020;8(4):e17530) doi: 10.2196/17530
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Introduction
Tobacco use presents a major preventable public health problem;
it is the leading cause of health deterioration and premature
death. The World Health Organization recognizes smoking as
a chronic systemic disease among the addictions capable of
producing high physical damage related to multiple diseases
[1]. Further, smoking kills over 7 million people annually, with
global costs estimated at US $1.4 trillion [2].
Validated approaches to facilitate smoking cessation include
nicotine replacement therapy, pharmacological treatment (ie,
bupropion and varenicline), and behavioral and psychological
support. Combining behavioral and psychological support with
pharmacological treatment is currently the most effective
intervention for achieving tobacco abstinence [3]. Moreover,
bupropion was shown to approximately double the likelihood
of long-term tobacco abstinence as compared with placebo [4].
Furthermore, varenicline (2 mg, total daily dose) was shown to
triple the likelihood of maintaining long-term tobacco abstinence
as compared with placebo [5]. Despite the proven efficacy of
these treatments, a meaningful number of smokers fail to stop
smoking, and many factors influence their success, including
the motivation to stop and continuous support.
Mobile and web-based interventions have been used to facilitate
effective behavioral changes in different health domains [6-9],
including smoking cessation. Scientific evidence has indicated
that mobile phone–based text messages supporting smoking
cessation were nearly 1.7 times more successful than a control
approach at 6 months [10]. It has been proven that the behavioral
change impact is higher when users receive multiple tailored
health recommendations [11,12]. However, in previous studies,
a traditional computer-tailoring approach was used to generate
such personalized health recommendations. Computer tailoring
involves the generation of patient-specific recommendations,
typically in the form of messages, by computers, and it is
performed after personal assessment to match the characteristics,
needs, and interests of the patients [13-16]. Cupertino et al [17]
recently piloted a 12-week smoking cessation program involving
text messaging with pharmacotherapy support, which showed
promising abstinence rates at 3 months and high participant
satisfaction. However, there is no evidence for the long-term
abstinence efficacy of mobile-based tailored interventions
combined with psychopharmacological therapies.
As part of the SmokeFreeBrain H2020 European Commission
project [18], the Social-Local-Mobile (So-Lo-Mo) study
investigated mobile and artificial intelligence (AI) technologies
(health recommender system [HRS]) as a complementary aid
to pharmacological treatments. The experimental intervention
focused on providing ubiquitous tailored support to patients
willing to stop smoking through a digital therapeutic mobile
app solution.
Participants receiving the So-Lo-Mo intervention were provided
with access to a code to be introduced in the app. The code
activated the app, connecting it with the hospital patient
database. The app automatically downloaded the necessary data
to initialize the app profile, reducing the burden of having to
create a user profile. The mobile app was connected with an AI
system designed to learn from patient interests through their
interactions with the app to dynamically (1) determine,
personalize, and send motivational messages to support smoking
cessation; (2) schedule the message delivery frequency
according to the transtheoretical model of behavioral change
[19]; and (3) calculate the most convenient time to send a
motivational message to support smoking cessation for each
patient. Specifically, the AI system used to tailor motivational
messages is a hybrid HRS, whose design has been presented
by Hors-Fraile et al [20].
The motivational messages were designed after conducting
semistructured interviews involving two smoking cessation
experts (a pulmonologist and a psychologist). Based on their
comments, we identified the following five different topics,
which were the most relevant for participants to succeed in their
smoking cessation process: (1) general motivation; (2) healthy
diet recommendations; (3) recommendations for an active
lifestyle; (4) positive reinforcement messages to meet activity
goals; and (5) benefits of being a nonsmoker. A total of 150
different messages were written for each topic by a health
communication and health promotion PhD candidate, and they
were validated by the two smoking cessation experts. This
number of messages was chosen to ensure that, even in the worst
case scenario where the AI system determines that a user needs
to receive messages of a single topic, no user would get the
same message twice during the intervention, as the maximum
JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 4 | e17530 | p. 2http://mhealth.jmir.org/2020/4/e17530/
(page number not for citation purposes)
Carrasco-Hernandez et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
number of messages that could be received is 150 during the
1-year study. This approach minimizes any potential robotic
and static feelings.
Messages included health communication and health promotion
strategies, such as creating empathy, adding new knowledge,
and changing existing misconceptions. The messages were short
(less than 100 words), written in simple Spanish, written using
a close and friendly tone, and written with easy-to-understand
terms to facilitate comprehension by smokers of all educational
levels. Other studies have used steps similar to the ones used
by us for message creation [21]. However, in our design, the
message content was not associated with any specific behavioral
change model. Each message was checked to be suitable for all
genders. When a message was clearly gender specific (ie,
relation between smoking and erectile dysfunction in men), an
alternate suitable message for the other gender was also designed
(ie, risks of smoking during pregnancy).
HRSs involve self-learning algorithms that can adapt to the
constantly evolving needs and interests of users and offer a high
level of personalization of recommendations, taking advantage
of the so-called “collective intelligence.” This is a new
recommendation generation paradigm that contrasts the
traditional tailoring approach, which provides static
recommendations according to user responses to usually lengthy
questionnaires. Thus, as this novel approach of tailoring is still
in its infancy [22], it is of high interest to determine the
relationship between the clinical outcomes of the So-Lo-Mo
study and this type of technology.
The main objective of this So-Lo-Mo study was to compare
usual psychopharmacological therapy (control group, CG) alone
and alongside the aforementioned digital solution (intervention
group, IG) for smoking cessation. The secondary objectives
were to analyze health-related quality of life (HRQoL) and
monitor healthy lifestyle and physical exercise habits.
Complementarily, we assessed the impact of the AI-generated




This 12-month, randomized, open-label, parallel-group trial
was performed at the Smoking Cessation Unit of Virgen del
Rocío University Hospital in Seville (Spain) between October
24, 2016, and October 24, 2018, and it complied with the
Declaration of Helsinki and Good Clinical Practice Guidelines.
The recruitment period closed on October 23, 2017. The local
ethics committee approved the study protocol, and written
informed consent was obtained from each participant prior to
inclusion. The clinical study design (NCT03553173) and
technical study design (NCT03206619) have been published
previously [23,24].
Randomization
A technician generated a random-group table (n=240) using
computer methods and following a 1:1 ratio between groups.
Clinicians enrolled the participants and assigned them to the
group mentioned in the table according to their enrolment
sequence. Participants were blinded to this allocation, as those
in the IG were told that the provided mobile app was part of
usual care. Participants in the CG were not informed about the
existence of the app and did not have access to it.
Study Population
Smokers were recruited during routine visits to our outpatient
clinic. The inclusion criteria were as follows: (1) age over 18
years and desire to stop smoking; (2) owning an Android
smartphone (as the mobile app was only available for Android
devices owing to time and resource constraints in the
development phase of this study and Android phones were more
likely to be owned by the target population owing to their lower
entry price as compared with iPhones); and (3) ability to interact
with the smartphone. Smartphone literacy was assessed by
asking the participants if they commonly use other text exchange
smartphone apps, such as Mail, SMS, and WhatsApp. The only
exclusion criterion was any previous adverse effect related to
the present pharmacological treatment.
Power Calculation and Recruitment
A sample size of 236 was calculated during the study design
phase, according to the following parameters: CI, 95%;
statistical power, 80%; CG success rate, 35%; IG success rate,
55%; and expected dropout rate, 20%. A total of 240 participants
were recruited and randomized for the stratified analysis.
Intervention and Control Groups
Usual care in the Smoking Cessation Unit of Virgen del Rocío
University Hospital consists of pharmacological therapy with
bupropion (ie, Zyntabac 150 mg; GlaxoSmithKline, Brentford,
UK) or varenicline (ie, Champix 0.5 mg or 1 mg; Pfizer, New
York, New York, USA) plus behavioral therapy. To facilitate
recruitment and avoid bias associated with treatment cost, the
SmokeFreeBrain project financed the drugs for usual care. Thus,
all participants received their assigned treatments free of charge.
Behavioral therapy, which was provided during face-to-face
follow-up consultations, included various psychological
techniques, including motivational interviews and
cognitive-behavioral therapy. This psychopharmacological
therapy was provided to both CG and IG participants. CG
participants (n=120) received psychopharmacological therapy
alone, whereas IG participants (n=120) received
psychopharmacological therapy and used the digital therapeutic
solution. Further information regarding enrollment, allocation,
and the study analysis phases is provided in Figure 1. The app
utilized behavioral techniques by sending personalized
motivational messages generated using AI with the intent to
achieve better smoking cessation rates by improving program
adherence and abstinence rates [20]. After the participant read
each message, the app asked the participant to rate how relevant
the message was for him or her, collecting feedback for the AI.
Complementing the core messaging feature, the mobile app had
other minor sections. These included a user profile linked to
the performed physical activity level collected by Google Fit
(Google, Mountain View, California, USA), four smoking
cessation benefit indicators (savings, smoke-free days, regained
life hours by not smoking, and number of nonsmoked cigarettes
since quitting), text-based information about smoking cessation,
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and a section containing relaxing and distracting elements
(breathing exercises and minigames). Figure 2 presents an
overview of the app features.
Figure 1. CONSORT diagram of the study.
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Figure 2. Structure of app features.
Measurements
Information from all participants included demographic (age
and sex) and socioeconomic data (profession and employment
status), consumption history (daily cigarettes smoked, living
with smokers, partner smoking status, smoking cessation
attempts, etc), clinical information (weight, height, blood
pressure, comorbidities, etc), nicotine dependence measured
using the Fagerström test for nicotine dependence [25], and
motivation to stop smoking according to the Richmond test
[26]. Safety was measured as the number of adverse events
related to pharmacological therapy.
The main clinical outcome was the 1-year smoking abstinence
rate measured by exhaled carbon monoxide (CO), which was
assessed using a CO tester (Micro+ Smokerlyzer; CoVita, Santa
Barbara, California, USA) and urine cotinine tests. Participants
with an exhaled CO level greater than 6 ppm were considered
smokers [27]. Urine cotinine (SmokeScreen test; Concept Smoke
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Screen Ltd, Lincolnshire, UK) is a colorimetric test that
measures the main nicotine metabolites, including cotinine.
Participants with a cotinine concentration greater than 200 ng/ml
were considered smokers [28]. Participants were considered
smokers when at least one of the aforementioned conditions
was met.
The HRQoL was assessed using the 36-item Short-Form Health
Survey (SF-36) that was validated in Spanish [29] and the
EuroQol 5-dimension 5-level (EuroQoL-5D-5L) questionnaire
[30]. Physical activity was measured using the International
Physical Activity Questionnaire (IPAQ) [31], and a healthy
lifestyle was interpreted via body mass index (BMI) variations
during follow-up consultations. A case report form, built upon
the OpenClinica [32] tool, was developed to facilitate
information management in the study. Information subsets were
registered according to the following schedule: basal and 15,
30, 60, 90, 120, 180, and 365 (±5) days after the basal
consultation [23].
The HRS impact on smoking cessation was assessed according
to the precision of the recommendations sent by the system.
Precision was calculated for both the message content
recommendations and the time to open the messages, as the
HRS aimed to optimize both variables. Further, we considered
the generated engagement of the user with the system and the
user appreciation of the messages as part of the technical
evaluation of HRS impact. The starting point to measure the
evolution of these metrics was the first day that a participant
rated a message (December 5, 2016), and the assessment
continued for the following 18 months to evaluate the progress.
Detailed descriptions of these metric calculations are presented
below.
Precision of the System
This measurement focused on the system’s effectiveness in
recommending relevant messages. The mobile app required the
user to rate all read messages at least once; otherwise, the user
could no longer interact with the app. There were three message
rating options (like, dislike, and neutral). The ratings were then
coded as 1 for “like,” −1 for “dislike,” and 0 for “neutral.” The
precision metric was calculated by dividing the number of hits
(messages rated as “like”) by the total number of sent messages
(precision_p). A modification of this measurement was
performed by considering “likes” and “neutrals” as hits
(precision_p_n,). We used two variants of precision to obtain
different perspectives on how the system performed in selecting
relevant messages. The second approach focused on minimizing
the negatively rated messages. Regardless of the variant, when
we code the hits as 1 and misses as 0, this metric is in fact an
arithmetic mean (we sum the number of hits and divide them
by the total number of sent messages). The value of this metric
ranges from 0 to 1. A higher value is associated with more
system precision. This is because on sending messages at
random, we expect 33% positive feedback, 33% neutral
feedback, and 33% negative feedback. However, when the
system learns and becomes more “intelligent,” the percentage
of negative feedback will decrease over time, increasing the
value resulting from this metric.
Time to Open Motivational Messages
This pertained to the arithmetic mean of the elapsed time
between the message being sent and opened in a 30-day period.
We assumed that this metric would decrease over time because
the system was expected to learn and become more “intelligent”
in predicting the best time for the user to open and read the sent
message.
Engagement With the System
To measure system engagement, we included a time stamp in
each sent message and compared it with the time stamp sent by
the app to the server when the user opened the given message.
Thus, the engagement metric was determined by the ratio of
rated messages calculated as the total of all rated messages from
one user divided by the total number of messages sent to that
user. As we coded each message rated with a “1” value and
divided the finding by the total number of sent messages, this
ratio coincides with the arithmetic mean. Thus, we assume that
a higher value is associated with more user interest in the
message and, consequently, higher user engagement. As this
metric measured the engagement of the user with the system
and not the engagement of the system with the user, we
considered the set date to stop smoking for each user as the
point to start counting each month. After this calculation, we
offset the start date for each user to the first day the user rated
the first message. This allowed us to compare the average
engagement of each user across time. Therefore, the results are
presented according the relative months to the user set date to
stop smoking (eg, M3 results are the results of the third month
after a participant stopped smoking). However, for one
participant, M3 could be April if the participant stopped smoking
in January, but for another participant, it could be December if
the participant stopped smoking in September. The measurement
of this follow-up was performed for the 12-month period that
each participant in the IG was enrolled in the study, as
participants in the CG did not use the mobile app.
Subjective Quality of the System
System quality was determined by the answers in an anonymized
five-level Likert-type appreciation questionnaire [24], making
it impossible to link the answers to the individual participants.
The questionnaire was completed by each participant at the end
of the 1-year follow-up period. The questions concerned the
HRS according to the Recommender Systems Questionnaire of
User Experience (ResQue) model [33] and the content of the
messages according to the I-Change model [34]. Of the 15
constructs of the ResQue model, 12 were represented in the
questions, as the remaining three did not apply to our HRS (ie,
purchase intention). All the answers reflected the level of
agreement of the participant with the proposed topics (1
indicating “totally disagree” and 5 indicating “totally agree”).
We assessed how participants perceived the quality of the system
after 12 months of usage by observing their questionnaire
response distributions, means, and SDs. Group comparisons
were not feasible owing to the complete anonymity of the
questionnaire. The aim was to measure the degree of possible
improvement of the system in the following areas included in
the questionnaire: quality of recommended items, interaction
adequacy, interface adequacy, perceived ease of use, perceived
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usefulness, control/transparency, attitudes, behavioral intentions,
and message content to influence smoking risk perception,
confidence, social support, and coping action support.
Statistical Analysis
Descriptive analyses of participant characteristics according to
absolute and relative frequencies for qualitative variables and
mean (SD) for quantitative variables were conducted. For the
primary endpoint and secondary outcomes (BMI, physical
activity, and HRQoL), analyses were conducted on a
per-protocol basis. These analyses included all participants who
adhered to the schedule of eight consultations (basal through
365 days after the basal consultation).
Regarding incomplete data analyses, homoscedasticity tests
were conducted among groups of cases with identical missing
data patterns to evaluate whether data were missing completely
at random [35]. A multinomial regression analysis was
performed to assess the variables influencing the probability of
a participant dropping out as compared with the probability of
the treatment being effective. A “no efficacy” category was set
as the reference category. As multinomial model effects are
relative to the reference category, to assess whether the
explicative variable effects were different between the “dropout”
and “efficacy” categories, the same model was adjusted using
the “dropout” category as a reference. Consequently, whether
the variable effects were different between the “dropout” and
“efficacy” categories was assessed. The relative risk ratio (RRR)
with 95% CI was used for each model.
Lost data analysis and multinomial logistic models showed
different patterns in participants who dropped out as compared
with the patterns in those who completed the study, regardless
of treatment efficacy. Therefore, smoking abstinence at 1 year
was analyzed using logistic regression models on a per-protocol
basis and intention-to-treat basis, and the effect measures were
the OR and 95% CI.
For the selection of logistic regression and multinomial logistic
models in per-protocol (n=94) analysis and intention-to-treat
(n=240) analysis, a two-stage strategy was adopted. In the first
step, the variable importance was quantified using Random
Forest [36] with the mean decrease in accuracy as the score.
Variables with a score above 0.5 were included in an Akaike
information criterion–based stepwise selection strategy. The
following two restrictions were applied to the final models
selected: (1) absence of a pattern in model residuals and (2)
variables with a generalized variance inflation factor [37] above
5 were not allowed in order to avoid collinearity.
To determine whether the HRS metrics had an impact on the
clinical outcomes, we divided IG participants in cessation and
no cessation subgroups at 12 months of the intervention.
Thereafter, we conducted t tests for the 12-month results of
precision, time to rate messages, and engagement, analyzing
each of these two subgroups.
Results
Characteristics
Both groups had similar baseline characteristics, except for the
maximum abstinence time and smoking cessation attempts
(Table 1).
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Table 1. Participant baseline characteristics.
P valueControl group (n=120)Intervention group (n=120)Characteristic
.0952 (43.3)65 (54.2)Female, n (%)
.0550.93 (10.85)48.38 (9.49)Age (years), mean (SD)
.5416.67 (3.60)16.94 (4.07)Age at smoking onset (years), mean (SD)
.4420.75 (9.39)21.45 (8.97)Daily cigarettes, mean (SD)
.6049 (40.8)45 (37.5)Lives with smokers, n (%)
.4365 (54.2)71 (59.2)Partner smokes, n (%)
.0451.14 (1.07)0.88 (1.08)Smoking cessation attempts, mean (SD)
.00313.68 (25.08)10.45 (25.49)Maximum abstinence time, mean (SD)
.7327.03 (6.46)27.02 (4.91)Body mass index, mean (SD)
.4838 (31.7)33 (27.5)Unemployed, n (%)





.1259 (49.2)46 (38.3)Comorbidities, n (%)
.061.08 (1.34)0.83 (1.25)Charlson index, mean (SD)
.385.60 (1.99)5.89 (1.91)Fagerström score, mean (SD)
.889.28 (0.88)9.32 (0.80)Richmond, mean (SD)
Efficacy (Unadjusted): 1-Year Smoking Abstinence
Rate
IG and CG participants who completed the study (per-protocol
analysis) achieved efficacy rates of 64.7% (CI 51.6%-77.8%)
and 40.0% (CI 25.7%-54.3%), respectively (P=.02; OR 2.75,
CI 1.20-6.29) and a number needed to treat of 4 (CI 2.0-19.0).
In the intention-to-treat analysis, IG and CG participants
achieved efficacy rates of 27.5% (CI 19.5%-35.5%) and 15.0%
(CI 8.6%-21.4%), respectively (P=.02; OR 2.15, CI 1.13-4.08)
and a number needed to treat of 8 (CI 4.0-43.0). Figure 3 shows
the efficacy evolution during the 1-year follow-up in each study
group according to both analytic approaches.
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Figure 3. Efficacy evolution during the 1-year follow-up.
Body Mass Index and Physical Activity
BMI variances were similar for both groups. In the IG and CG,
the mean BMI variances were 1.01 (CI 045-1.57) and 1.10 (CI
0.72-1.48), respectively, at 6 months and were 1.47 (CI
0.90-2.03) and 1.22 (CI 0.67-1.75), respectively, at 12 months.
The between-group mean BMI differences at 6 and 12 months
were −0.09 (CI −0.77 to 0.60; P=.80) and 0.25 (CI −0.53 to
1.03; P=.52), respectively.
According to the observed IPAQ scores, physical activity
evolution patterns were similar in both study groups. Moreover,
in the IG, 12.8% (6/47) and 25.5% (13/51) of participants
increased their physical activity at 6 and 12 months, respectively,
whereas 14.9% (7/47) and 13.7% (7/51) of participants reduced
it at the corresponding points. On the other hand, in the CG,
14.6% (6/41) and 24.4% (11/45) of participants increased their
physical activity at 6 and 12 months, respectively, whereas
24.4% (10/41) and 8.9% (4/45) of participants reduced it at the
corresponding points. Table 2 summarizes the BMI and IPAQ
results.
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Table 2. Body mass index, physical activity and health-related quality of life variances in each group.
P valueControl groupa (n=45)Intervention groupa (n=51)Variable
BMIb changes (kg/m2)
.801.10 (0.72 to 1.48)1.01 (0.45 to 1.57)At 6 monthsc
.521.22 (0.67 to 1.75)1.47 (0.90 to 2.03)At 12 months
IPAQd changes at 6 monthsc
.476 (14.6)6 (12.8)Improvement
25 (61.0)34 (72.3)No change
10 (24.4)7 (14.9)Worsening
IPAQ changes at 12 months
.7311 (24.4)13 (25.5)Improvement
30 (66.7)31 (60.8)No change
4 (8.9)7 (13.7)Worsening
VASe changes
.963.88 (−0.57 to 8.32)4.04 (−0.76 to 8.84)At 6 monthsc
.332.78 (−1.86 to 7.41)5.78 (1.60 to 9.97)At 12 months
SF-36f changes at 12 months
.985.33 (1.43 to 9.24)5.39 (2.18 to 8.61)Physical function
.345.69 (0.43 to 10.96)2.82 (−0.47 to 6.10)Physical role
.655.71 (−1.07 to 12.49)3.78 (−1.52 to 9.09)Body pain
.996.38 (0.73 to 12.02)6.35 (1.83 to 10.87)General health
.946.94 (1.75 to 12.14)7.23 (1.92 to 12.54)Vital
.067.78 (2.82 to 12.73)0.74 (−4.86 to 6.33)Social
.733.70 (−0.78 to 8.19)4.90 (−0.22 to 10.02)Emotional
.724.78 (−1.06 to 10.61)3.33 (−2.12 to 8.79)Mental
aData are expressed as mean (95% CI) or n (%).
bBMI: body mass index.
cData are missing.
dIPAQ: International Physical Activity Questionnaire.
eVAS: visual analog scale.
fSF-36: 36-item Short-Form Health Survey.
Health-Related Quality of Life
Based on the EuroQoL-5D-5L questionnaire results, both groups
had improved HRQoL scores at 6 months. Although the IG
showed a greater improvement at 12 months, the difference was
not statistically significant (Table 2). The mean between-group
visual analog scale differences at 6 and 12 months were 0.17
(95% CI −6.36 to 6.70) and 3.01 (95% CI −3.14 to 9.16),
respectively. Regarding the SF-36 dimensions, both groups
showed improvement at 12 months, although there were no
significant between-group differences. Table 2 summarizes the
HRQoL results.
Safety: Adverse Events
Nineteen adverse events (11/19 [58%] associated with bupropion
and 8/19 [42%] with varenicline) were identified in 14 IG
participants (11.7%), whereas 23 adverse events (10/23 [43%]
associated with bupropion and 13/23 [57%] with varenicline)
were identified in 13 CG participants (10.8%) (P=.84).
The most frequent events associated with bupropion were
headache (6/21, 28.6%), insomnia (4/21, 19.0%), vertigo (4/21,
19.0%), acute abdominal pain (2/21, 9.5%), and others (5/21,
23.8%), and those associated with varenicline were nausea (6/21,
28.6%), acute abdominal pain (4/21, 19.0%), insomnia (3/21,
14.3%), vomiting (2/21, 9.5%), and others (6/21, 28.6%).
Lost Data Pattern Analysis
The pattern of missing efficacy variable values was not totally
random (P<.001). Multimedia Appendix 1 shows the variables
whose distributions differed depending on the group; the values
were not equally distributed between the participants who
dropped out and those who completed the study. Table 3 shows
the parameters estimated by the multinomial logistic regression
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model for each of the variable effectiveness levels (no efficacy, efficacy, and dropout) with respect to the reference category.
Table 3. Multinomial logistic regression.
P value95% CIRRRaVariable







































aRRR: relative risk ratio.
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Importantly, the probability of being in the “efficacy” category
was higher for IG participants as compared with the “no
efficacy” category (RRR=3.25; P=.01). Furthermore, increasing
the baseline Fagerström score (higher nicotine dependence) in
a unit rendered a smoker more likely to belong to the “dropout”
category as compared with the “no efficacy” category
(RRR=1.31; P=.03). Increasing the maximum smoking
abstinence time reduced the probability of a smoker being in
the “dropout” category as compared with the “no efficacy”
category (RRR=0.81; P=.03). Furthermore, the probability of
being in the “dropout” category increased for participants using
bupropion as compared with the “no efficacy” category
(RRR=0.36; P=.01).
Efficacy (Adjusted): 1-Year Smoking Abstinence Rate
Table 4 shows the logistic regression analysis results for
participants who completed the study (per-protocol basis).
Notably, for the IG participants, the efficacy was 3.45 times
higher with adjustment for age, motivation to stop smoking
(Richmond scale), and comorbidity level. The efficacy
probability decreased by 28.9% when a participant was not in
the IG, with adjustment for the rest of the variables.
The results of the lost data pattern analysis and those obtained
from the multinomial logistic models showed different patterns
in participants who dropped out as compared with those who
completed the study, regardless of treatment efficacy. However,
as the variables associated with the dropout probability indicated
a lack of treatment efficacy (belonging to the CG, short
withdrawal period duration, fewer attempts, greater number of
daily cigarettes, and baseline Fagerström score), a value of 0
(no efficacy) was assigned to participants who dropped out of
the study. Therefore, the worst possible scenario models efficacy
by intention-to-treat using a logistic regression model (Table
5).
These findings demonstrate that intervention efficacy was 3.13
higher with adjustment for the rest of the variables. Hence, the
probability of long-term smoking cessation using the digital
therapeutic solution was over three times higher than the
probability of cessation with usual care alone.





.031.07-3.521.90Motivation to stop smoking (Richmond score)
.720.16-3.600.76Charlson index, medium comorbidity
.010.01-0.450.07Charlson index, high comorbidity







.030.68-0.980.82Nicotine dependence (Fagerström score)
.0491.02-2.691.62Motivation for smoking cessation (Richmond score)
.890.30-2.550.93Low physical activity (IPAQa)
.470.19-1.950.66Medium physical activity (IPAQ)
aIPAQ: International Physical Activity Questionnaire.
Health Recommender System Impact on Smoking
Cessation Outcomes
A total of 17,111 messages and 2617 ratings were provided in
the study, and there were 2311 ratings during the 12 months of
follow up, 261 in the presmoking cessation phase, and 45 at 13
months or later, which were not part of this analysis.
Precision
The t test results for each month indicated that there were no
significant differences for system precision_p or precision_p_n
in the cessation and no cessation subgroups. The detailed results
are presented in Multimedia Appendix 2. A bimonthly graphical
representation of the evolution of precision_p and precision_p_n
over time is shown in Figure 4.
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Figure 4. Evolution of health recommender system precision and number of users providing ratings by subgroup. M: month; precision_p: precision
calculated by dividing the number of hits (messages rated as “like”) by the total number of sent messages; precision_p_n: precision calculated by dividing
the number of hits (messages rated as “like” and “neutral”) by the total number of sent messages.
Time to Open Messages
We performed t tests (results are shown in Multimedia Appendix
2) and found no significant difference between the cessation
and no cessation subgroups at any time point. A bimonthly
graphical representation of the evolution of the time-to-open
metric is shown in Figure 5.
Figure 5. Mean time between a message being sent and opened. M: month.
Engagement
The t tests shown in Multimedia Appendix 2 indicate that there
were significant differences between the cessation and no
cessation subgroups in only the first 7 (P=.04), 8 (P=.03), and
10 (P=.04) months, showing a trend toward higher engagement
in the cessation subgroup. A bimonthly graphical representation
of the evolution of the IG participants’ engagement with the
system over time is shown in Figure 6.
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Figure 6. Evolution of user engagement. M: month.
Perceived Quality
Only 32 participants volunteered to respond to the questionnaire.
However, not all participants who responded to the questionnaire
completed it. The results are presented in Table 6.
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Table 6. Answers to the perceived quality questionnaire.
SDMeanMaximum scoreMinimum scoreNQuestion
0.404.195432The messages recommended to me matched my interests.
0.504.065332The messages recommended to me were novel.
0.514.475432The messages recommended to me were diverse.
0.604.035332The layout of the message interface was adequate
0.484.345432I found it easy to tell the system what I like/dislike.
0.663.635332I felt in control of modifying my interest profile.
0.374.005330I became familiar with the messaging system very quickly.
0.484.035331I understood why the messages were recommended to me.
0.434.235431The messages gave me good suggestions.
0.494.355431Overall, I am satisfied with the messages.
0.553.975331The messages can be trusted.
0.723.615331I would recommend the use of the message recommendations to my friends
who smoke.
0.643.715331The messages convinced me that I am at risk for health problems if I do not
quit smoking.
0.574.065331The messages convinced me that my smoking is a risky habit.
0.663.675330The messages convinced me of the advantages of smoking cessation.
0.543.685331The messages showed me how to get social support from others during ces-
sation.
0.264.005331The messages helped me feel confident that I could successfully quit smoking.




The combination of our digital therapeutic solution with
psychopharmacological treatment was more effective in
achieving tobacco abstinence at 12 months as compared with
psychopharmacological treatment alone. According to the
per-protocol analysis findings, abstinence was 2.75 times higher
among IG participants than among CG participants (adjusted
OR of 3.45 for age, motivation, and comorbidity level).
According to the intention-to-treat analysis, abstinence was 2.15
times higher among IG participants than among CG participants
(adjusted OR of 3.13 for age, drug used, maximum abstinence
time, nicotine dependence, motivation, and physical activity).
Moreover, our findings suggest that the probability of dropout
increased for participants who used bupropion and had high
nicotine dependence, whereas a high maximum smoking
abstinence time reduced this probability.
Despite mobile apps offering several advantages over traditional
smoking cessation methods, few studies have examined the
content quality or the effectiveness of apps promoting smoking
cessation [38-40]. To the best of our knowledge, this study
provides the first scientific evidence of the efficacy of a
behavioral change intervention via a mobile app powered by
AI for smoking cessation at a 1-year follow-up. Furthermore,
no other study has provided statistically significant results for
a mobile intervention used in combination with smoking
cessation drugs. Previous studies published their cessation
results with 6 months of follow-up at the most, as described in
the comparison with prior work subsection below. We provide
evidence for the long-term impact of our digital therapeutic
solution, with a follow-up period that is double of the follow-up
period in previous studies. Further, this study is the first to
analyze physical activity via the IPAQ after smoking cessation.
Physical activity evolution patterns were similar in the IG and
CG, with an increase in the percentage of participants showing
improved physical activity and no significant difference between
the IG and CG participants.
Weight gain during the first year of abstinence concerns smokers
[41], and it may be a potential barrier to pursue smoking
cessation. In this study, weight gain, measured by an increase
in BMI, occurred in both groups. The app did not affect weight
gain as there was no difference between the IG and CG.
A previous review showed that a higher number of cigarettes
smoked was associated with a lower QoL. Additionally, a low
QoL and depression were related with lower odds of successfully
stopping smoking [42]. Participants who received treatments,
including varenicline and bupropion, reported QoL
improvements and increased abstinence duration as compared
with those who did not receive pharmacotherapy [42,43]. The
present results are comparable to these findings. There was a
positive trend in the HRQoL scores reported by the IG, but with
no relevant difference as compared with the scores in the CG.
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The complementary technical results showed that the HRS is
able to learn the participants’ interests regarding the support
message topics for smoking cessation. The system was more
precise at the end of the intervention than at the beginning, as
was expected for a recommender system. However, the
minimum precision reached was very high (over 96%). We
believe that there may be different reasons for this extremely
high value. For instance, it could be due to the implemented
hybrid HRS algorithm that mitigates the cold start problem and
accurately recommends messages from the beginning according
to a weighting formula described in a previous publication [20].
Additionally, it could be due to participants believing that their
ratings would be viewed by health care professionals; hence,
they modified their ratings toward a higher value than they
otherwise would. This potential Hawthorne effect would be a
limitation for digital health not identified in a recent study [44],
as HRSs are only starting to be used in health care. Another
reason may be that the system did not allow sufficient
granularity for the users to vote; the participants were only
afforded three rating options. A wider spread of rating options
may have contributed to the differentiation of message relevance
to a greater extent (for instance, separating fair, good, and
entirely accurate messages). The statistical analysis did not find
a significant difference in the precision achieved between
participants who were successful in smoking cessation and those
who were not successful. Hence, the achieved precision over
time cannot be considered a predictor of smoking cessation, as
the HRS recommended motivational messages equally well for
all participants.
The time-to-open metric results showed that the HRS was not
able to predict the best time to send a message for a decrease
in the time between the message being sent and the user opening
the message. This may be due to several factors influencing
participant behavior other than the time they receive a message,
which were not considered in the HRS. To improve the time,
variables, such as the position of the phone, location, last
activity, and cessation day, should be considered for inclusion
as parameters in the HRS.
The generated engagement by the system showed statistical
significance (P=.04) between the cessation and no cessation
subgroups after the first 6 months of the intervention, favoring
a higher engagement for those who managed to stop smoking.
This is in line with the intuitive assumption that participants
who engaged with the system to a greater extent received greater
benefit and consequently were less likely to relapse. However,
these differences were not significant at 9, 11, and 12 months
owing to a decrease in the number of participants to such an
extent at these points that the statistical power was limited.
As not all participants in the IG completed the perceived quality
questionnaire and the questionnaire was anonymous, it is
impossible to ensure that any conclusion derived from the
collected results is not biased. However, the results showed a
clearly positive perception of the quality of the system.
Reasonably, only those who managed to stop smoking and
presumably benefited from the system provided answers to the
questionnaire, as they would have been more motivated to
respond. On the other hand, participants who dropped out,
probably due to relapse, would have not been interested in
completing the questionnaire. However, it could also be argued
that those who did not manage to stop smoking would have
been willing to provide negative feedback on the system in the
anonymized questionnaire. Nevertheless, the positive trend of
the answers favors the first scenario. For similar research
practices in the future, we suggest following a design that forces
participants to respond to the questionnaire but still preserves
their anonymity. This could be achieved by including the
questionnaire in a previous stage of the trial to avoid an effect
by the high dropout rate associated with digital interventions
for smoking cessation.
The features of the presented AI-based digital therapeutic
solution enabled the system to effectively support smoking
cessation by providing support and advice for facilitating
abstinence, enhance motivation, and clearly show a benefit [45].
The HRS was well perceived by the participants. Over time, it
identified the most relevant motivational messages to send to
each participant, and those who were engaged with the system
to a great extent managed to successfully stop smoking by the
end of the intervention. Therefore, this digital therapeutic
solution may alleviate the known drawbacks of intensive
complementary behavioral interventions for smoking cessation,
which, despite their benefits, require extensive availability of
well-trained professionals, leading to limited scalability, poor
accessibility, and smoker resignation owing to long waiting
times [46].
Limitations
In previous similar studies, the dropout rate was usually very
high, reflecting the difficulty of smoking cessation and high
relapse rate [3]. In this study, the dropout rates were 57.5% and
62.5% in the IG and CG, respectively. A high dropout rate may
bias the results; however, the dropout rate was similar between
the groups, minimizing the possibility of bias. The efficacy of
the intervention was verified by per-protocol and
intention-to-treat analyses, providing a more realistic picture
while reducing the importance of dropout or full treatment
compliance. Moreover, an analysis of the characteristics of the
dropout and no dropout categories within each group was carry
out, and the same pattern was obtained between both groups
(Multimedia Appendix 3). These findings suggest the potential
benefit of the intervention, as participants did not experience
abnormal adverse effects and were more likely to be abstinent
after 1 year. Nevertheless, further exploration of its efficacy is
needed for validation in other cultures, and studies should
include a larger sample size and real-world data.
We found some random inconsistent values in the entries of the
registered time, including duplicate entries and negative time
values. The presented results correspond to filtered data
(removing such values). Removal of these values reduced data
quality for the metric, and the findings may not accurately
represent the entire participant group. These inconsistent values
may have been registered owing to glitches in communication
between the smartphone app and the tracking system on the
server.
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Metrics for engagement at the aggregated level could not be
provided as anticipated in the technical protocol because the
software service used to track user data is not able to retrieve
information from data older than 2 years. This information was
not listed in the features of the service when it was selected for
the purposes of the study. We encourage future researchers to
use in-house user data tracking services to avoid relying on
third-party software.
Comparison With Prior Work
Previous studies have explored the use of mobile apps
supporting smoking cessation. The SmartQuit study tested the
feasibility, acceptability, preliminary efficacy, and mechanism
of behavioral change of an innovative smartphone-delivered
acceptance and commitment therapy app for smoking cessation
in 196 adult participants and reported a successful cessation
rate of 13% after 2 months of follow-up [47].
In another study, the authors assessed the efficacy of an
interactive smoking cessation decision–aid app in 684 adults
and reported a successful cessation rate of 10.2% [48].
Additionally, an app-based mindfulness training program for
smoking cessation was assessed in 143 participants, and a
successful cessation rate of 11.1% was achieved [49]. A parallel,
double-blind, randomized, controlled, two-arm trial compared
the efficacy of an evidence-informed smartphone app for
smoking cessation (Crush the Crave) to that of an
evidence-informed self-help guide (On the Road to Quitting)
in 1599 subjects and reported successful cessation rates of 7.8%
and 9.2%, respectively [50]. In all these studies, the abstinence
rate was reported at 6 months from baseline. However, they did
not include pharmacological treatment as part of the
intervention, which is a clear difference from the approach in
our study. It is remarkable that the dropout rates for both the
IG and CG identified in this study are consistent with those
previously reported in the literature [50].
Research has been performed on intervention efficacy for the
use of an app specifically designed to support the smoking
cessation process when added to pharmacological therapy. The
preliminary efficacy of an app designed to prompt smokers to
engage in physical activity was assessed at 6 months of
follow-up in 44 regular smokers who received the app in
addition to behavioral smoking cessation counselling, physical
activity promotion, and pharmacological support, and the overall
abstinence rates were 36% in an intention-to-treat analysis and
53% in a complete-case analysis [51]. In this previous study,
the allocation of pharmacological treatment (varenicline and
nicotine replacement therapy) was not controlled by the study
protocol, which hinders the comparability of the results with
those of our study. Additionally, in a randomized pilot study,
a 12-week course of varenicline was prescribed to both arms to
assess the feasibility and acceptability of the My Mobile Advice
Program (MyMAP) smoking cessation app and estimate its
effects on smoking cessation and medication adherence [52];
however, its efficacy could not be evidenced owing to the small
sample size (n=33).
As stated in the conclusion section of a recent systematic review
[53] that included 26 studies (n=33,849) involving text
messaging and app-based smoking cessation interventions, there
is moderate certainty evidence that automated text
message–based smoking cessation interventions result in greater
smoking cessation rates as compared with minimal smoking
cessation support and there is moderate certainty evidence of
the benefit of text messaging interventions in addition to other
types of smoking cessation support as compared with smoking
cessation support alone. The evidence of the comparison of
smartphone apps with less intensive support had very low
certainty, and further randomized controlled trials are needed
to test these interventions. In this sense, the results of this study
aim to contribute to an increase in the certainty level of the
available evidence in this domain.
When focusing on the assessment of recommender systems,
such as the one used in this study, the scientific community has
extensively concentrated on improving the performance of
recommender system algorithms with different metrics [54-58],
mainly in nonhealth contexts, such as leisure [59] and
e-commerce [60,61]. Among these approaches, common
assessments for prediction accuracy are as follows: (1) mean
absolute error and root mean squared error, as well as their
normalized and averaged variants to predict ratings that users
would give to items when the actual recommendation ratings
of the items are known for the whole test set; (2) precision,
recall, and false positive rate [58,62] for prediction of the usage
of the recommendations; and (3) normalized discounted
cumulative gain when the system presents a large list of
elements (similar to a search in Google), where we expect that
the most relevant elements are shown at the top of the list; and
(4) coverage of the recommendation set [63]. Other authors
have proposed the use of surveys to assess recommender
systems, such as ResQue [33].
Regarding the evaluation of mobile Health (mHealth) apps for
behavioral change, such as the one included in this study, some
authors have proposed evaluation procedures, such as the
National Institute for Health and Care Excellence adaptation
[64], the Mobile App Rating Scale framework [65], and the
Application Usage Factor, which is defined as the logarithm of
the product of the number of active users of a mobile app and
the median number of daily uses of the app [66]. Despite these
attempts to set a methodological framework to assess mHealth
apps, they still lack standardization and comprehensiveness
[67]. In a recent study, McKay et al identified that there was no
available related best practice [68]. Instead, they proposed the
following generic guidelines for what these types of evaluations
should include: (1) assessment of the quality of health-related
content; (2) review of the usability and functionality of the app;
and (3) critique of the app potential with regard to behavioral
change promotion.
Despite the lack of consensus on specific evaluation methods,
it is well accepted that engagement is a key element for mHealth
solutions to be successful [69]. Engagement has been considered
a positive early indicator for behavioral change [70], as the
process of behavioral change requires time. Previous studies
showed that technologies supporting reaching a specific behavior
health goal help people stick to the desired goal [71,72]. Further,
Scherer et al [73] found a significant positive correlation
between engagement and fewer dropouts in an mHealth
intervention. A recent approach to provide an engagement score
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for a mHealth app is the Engagement Index proposed by Taki
et al [74]. To calculate the score, the authors combined the
number of pages in the app that a participant visited each day,
number of app accesses during the program, number of push
notifications opened, elapsed time between app accesses, and
subjective answers to a questionnaire. However, achieving user
engagement is difficult [75], and its level could be improved
[76-78]. Therefore, it seems reasonable to consider engagement
as a key metric for digital health solutions. However, the
definition of engagement varies among studies. For instance,
Iacoviello et al [79] considered the number of times users
opened an app, number of interactions they had, and number of
weeks in which users had at least one interaction with the
program as indicators of engagement. Owen et al [80]
determined engagement by calculating several variables, such
as the number of downloads and number of sessions (a session
being basically opening of the app). Yet, it is common to just
use opening the app as an indicator of engagement, as adopted
in previous studies [40,81]. All these engagement interpretations
fall under the categorization of “system usage data” proposed
by Short et al [82], which is most frequently used. However,
other engagement measurement approaches have been proposed,
such as ecological momentary assessments, psychophysiological
measurements, and qualitive methods.
In our So-Lo-Mo study, the HRS was intuitively related to user
engagement, as some studies have shown that good and timely
recommendations to stop smoking motivate users to read more
future recommendations [74,83]. Hence, we proposed a
combination of qualitative and quantitative metrics, which
measure the intended purpose of the system (quality of the
recommendations, engagement of the participants with the
system, and participants’ perception of the system). To our
knowledge, this is the first assessment involving a HRS.
However, in the case of smoking cessation, low engagement
may not necessarily result in low impact on behavioral change,
as some studies have previously shown the “gateway effect”
[84] and “happy abandonment” [85]. There are several reasons
for this, including the burden of the required interactions as
compared with perceived outcomes or the internalization of
health habits denoting that support is perceived as no longer
necessary [86]. Consequently, we needed to carefully analyze
the engagement of users across time points keeping in mind all
these factors to extract any conclusions. Thus, our system’s
intended usage [82] is expected to be higher during the first
weeks of the smoking cessation process and to progressively
decrease until there is no engagement with the system, which
will be reflected in engagement measurements.
Conclusions
The So-Lo-Mo intervention offers a promising strategy for
smoking cessation. The use of this digital therapeutic solution
alongside pharmacological treatment was much more efficacious
in achieving tobacco abstinence as compared with
pharmacological treatment alone at the 1-year follow-up.
However, this intervention did not improve participant HRQoL
and physical activity levels.
Analysis of the impact of the HRS showed that participants
benefited from the recommendations, and those who engaged
with the system were more likely to succeed in smoking
cessation. Therefore, the proposed HRS had a positive impact
on the participants and offered them personalized and relevant
messages, although it could not determine when supportive
messages should be sent to minimize the time until they are
read.
Health care providers should consider incorporating this digital
therapeutic solution in their usual care, as it can facilitate
positive outcomes for participants willing to stop smoking.
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BMI: body mass index
CG: control group
EuroQoL-5D-5L: EuroQol 5-dimension 5-level
HRS: health recommender system
IG: intervention group
IPAQ: International Physical Activity Questionnaire
ResQue: Recommender Systems Questionnaire of User Experience
RRR: relative risk ratio
SF-36: 36-item Short Form
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